Lixte Biotechnology Holdings Financial Overview
Lixte Biotechnology Holdings's market cap is currently $25.40M. The company's EPS TTM is $-1.594; its P/E ratio is -3.44; Lixte Biotechnology Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.